One other study from Finland [54] evaluated 87 NSCLC patients enriched for non-smokers and adenocarcinomas, and displayed an ALK fusion frequency of 5.7 %, which would also be considered as comparably low for selected patients. The gene discussed is ALK; the disease is adenocarcinoma.